21 Jul, 2020, 16:31 ET
BIRMINGHAM, Ala., July 21, 2020 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has placed land under contract and plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Lakeland, Florida, to be named Encompass Health Rehabilitation Hospital of Lakeland.
Complementing local acute care services, the hospital will care for patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. The hospital will provide physical, occupational and speech therapies that aim to restore functional ability and quality of life and 24-hour care by registered nurses, many of whom are certified in rehabilitation nursing.
The medical staff will be comprised of physicians experienced in physical medicine and rehabilitation as well as other specialties such as internal medicine, cardiology, infectious disease and nephrology to assist in the medical management and support a complex patient population.
"The hospital we will build in Lakeland is a freestanding, state-of-the-art physical plant. The design is specific to caring for rehabilitation patients and is based off our experience operating 12 hospitals in Florida and 136 hospitals throughout the nation," said Linda Wilder, president of Encompass Health's southeast region. "Additionally our staff is dedicated to, trained and singularly focused on the specialty practice of physical rehabilitation, which will make the services we bring a high-quality complement to the existing strong healthcare services in the area. We are very glad to have the opportunity to serve the patients and community of Lakeland and the surrounding area."
The hospital will feature all private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, cafeteria, dining room, pharmacy and therapy courtyard.
The planned hospital, once opened, will become part of Encompass Health's national network of inpatient rehabilitation hospitals and home health and hospice agencies. The Company's Florida footprint currently includes 12 inpatient rehabilitation hospitals, a hospital under construction in north Tampa and 19 home health locations. A construction timeline for the hospital has not yet been established.
About Encompass Health
As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 136 hospitals, 245 home health locations, and 83 hospice locations in 39 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter and Facebook.
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete and integrate this project consistent with Encompass Health's growth strategy, including realization of anticipated revenues, cost savings, and productivity improvements arising from the related operations and avoidance of unforeseen exposure to liabilities; the continued spread of COVID-19, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to the COVID-19 pandemic; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2019 and Form 10-Q for the quarter ended March 31, 2020.
Hillary Carnel | 205 970-5912
Investor Relations Contact:
Crissy Carlisle | 205 970-5860
SOURCE Encompass Health Corp.
Share this article